Alstrom syndrome screening: Difference between revisions
Jump to navigation
Jump to search
m Bot: Adding CME Category::Cardiology |
|||
| Line 11: | Line 11: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
[[CME Category::Cardiology]] | |||
[[Category:Genetic Disease]] | [[Category:Genetic Disease]] | ||
| Line 17: | Line 21: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Needs overview]] | [[Category:Needs overview]] | ||
Latest revision as of 20:06, 14 March 2016
|
Alstrom syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Alstrom syndrome screening On the Web |
|
American Roentgen Ray Society Images of Alstrom syndrome screening |
|
Risk calculators and risk factors for Alstrom syndrome screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]; Raviteja Guddeti, M.B.B.S. [3]
Screening
- Fasting blood glucose levels are evaluated every two to three months. Closer follow-up is needed if fasting or postprandial blood glucose concentrations are elevated.
- Urinalysis and plasma concentrations of electrolytes, uric acid, BUN, and creatinine should be estimated twice-yearly.
- Annual assessment of vision and hearing; weight, height, and body mass index; heart (including echocardiography); plasma insulin concentration; lipid profile; plasma ALT, AST, and GGT concentrations; pulmonary function; thyroid function.
- Renal and bladder ultrasound examinations should be conducted if symptomatic and/or if urinalysis is abnormal, every one to two years.